Genomic context: C. concisus strains harbor diverse respiratory and metabolic pathways, including periplasmic reductases (e.g., BisA) .
Functional analogs: Other Campylobacter spp. (e.g., C. jejuni) encode NDKs, but their roles in pathogenesis remain unexplored .
Given NDK’s involvement in nucleotide homeostasis and stress adaptation, potential roles in C. concisus could include:
Metabolic adaptation: Supporting anaerobic respiration via nucleotide recycling, critical for survival in the gastrointestinal niche .
Virulence modulation: Interactions with host cell signaling pathways, as seen in fungal NDKs .
Recombinant protein characterization: Cloning, expression, and enzymatic profiling of C. concisus NDK.
Genetic knockout studies: Assessing impacts on growth, virulence, and oxidative stress response.
Host-pathogen interactions: Screening for NDK-dependent signaling in intestinal epithelial cells.
KEGG: cco:CCC13826_0990
STRING: 360104.CCC13826_0990
Campylobacter concisus is a Gram-negative, curved bacterium that requires microaerobic or anaerobic conditions enriched with H₂ for growth. Cells measure (0.5-1) × (2-6) μm and are motile via a single polarized flagellum . The organism primarily colonizes the human oral cavity, with detection rates of 97-100% in saliva samples from healthy individuals . C. concisus has gained research significance due to its association with inflammatory bowel disease (IBD), including both Crohn's disease and ulcerative colitis.
Nucleoside diphosphate kinase (ndk) from C. concisus represents an important research target because:
As a housekeeping enzyme involved in nucleotide metabolism, NDK is essential for bacterial growth and survival
NDK proteins in other bacterial pathogens have been implicated in virulence mechanisms
Studying C. concisus NDK may provide insights into its metabolic adaptations and potential contribution to pathogenesis
C. concisus strains are classified into two distinct genomospecies (GS):
These genomospecies show significant genetic differences:
G+C content differs with medians of 37.56% for GS1 and 39.51% for GS2
Intra-GS Average Nucleotide Identity (ANI) values range between 93% and 96%
These genomic differences may result in variation in the NDK protein between strains from different genomospecies. Researchers should consider isolate selection carefully, as genomospecies differences may impact experimental outcomes, including recombinant protein expression, structure, and function.
Detection methods significantly impact C. concisus research outcomes, as demonstrated by comparative studies:
| Detection Method | Patient Group | Detection Rate |
|---|---|---|
| Genus-specific PCR | Children with CD | 19% (10/54) |
| Genus-specific PCR | Healthy controls | 12% (4/33) |
| Genus-specific PCR | Non-IBD controls | 0% (0/27) |
| Nested PCR | Children with CD | 65% (35/54) |
| Nested PCR | Healthy controls | 33% (11/33) |
| Nested PCR | Non-IBD controls | 37% (10/27) |
| Various methods | Adults with UC | 33.3% (23/69) |
| Various methods | Healthy controls | 10.8% (7/65) |
When amplifying the NDK gene, researchers should employ multiple detection methodologies, as standard PCR may significantly underestimate prevalence. Additionally, collection of multiple biopsies greatly increases detection rates compared to single biopsies .
When selecting C. concisus strains for NDK studies, researchers should consider:
Genomospecies classification: Clearly identify and report whether strains belong to GS1 (ATCC 33237ᵀ-like) or GS2 (CCUG 19995-like) to account for potential genetic variations in the NDK gene .
Source of isolation: Oral isolates may differ from intestinal isolates, potentially affecting NDK characteristics . Protein profiling studies have shown that only some oral strains match intestinal strain profiles .
Clinical context: Consider whether strains were isolated from healthy individuals or IBD patients, as this may correlate with genomospecies distribution and potentially NDK properties.
Comparative approach: Ideally, analyze NDK from multiple strains representing both genomospecies to identify potential structural or functional differences that may correlate with different clinical manifestations.
Validation: Sequence verification of the NDK gene is essential, especially when using clinical isolates, due to the potential presence of mixed Campylobacter species in IBD patients (20.3% in UC vs. 4.6% in controls) .
The selection of an appropriate expression system should consider C. concisus-specific characteristics:
E. coli-based systems:
BL21(DE3) derivatives with rare codon supplementation (Rosetta, CodonPlus) are recommended due to the low G+C content of C. concisus (37.56-39.51%)
Consider reduced-temperature expression (16-25°C) to improve protein solubility
Evaluate both aerobic and microaerobic induction conditions, as C. concisus is microaerophilic
Alternative expression hosts:
Campylobacter jejuni expression systems may provide more native-like conditions
Cell-free expression systems can be advantageous if the protein forms inclusion bodies
Fusion tags strategy:
N-terminal solubility-enhancing tags (MBP, SUMO) may improve expression
Include protease cleavage sites for tag removal
Consider both N- and C-terminal tagging approaches
Expression verification:
Western blotting with anti-His or anti-NDK antibodies
Activity assays to confirm functional expression
Mass spectrometry to verify protein identity
Several C. concisus-specific considerations affect purification strategies:
Oxygen sensitivity: As C. concisus requires microaerobic or anaerobic conditions for growth , its proteins may be sensitive to oxidation. Consider:
Addition of reducing agents (DTT, β-mercaptoethanol) in buffers
Performing purification steps under nitrogen atmosphere
Including oxygen scavengers in final storage buffers
Oligomeric state: Bacterial NDKs typically form hexamers, but this should be confirmed for C. concisus NDK using:
Size exclusion chromatography
Native PAGE
Dynamic light scattering
Stability considerations:
Test pH stability across a range of conditions (pH 6.0-8.5)
Evaluate thermal stability using differential scanning fluorimetry
Determine appropriate storage conditions (buffer composition, temperature)
Contaminant removal:
Include additional purification steps (ion exchange, hydrophobic interaction chromatography)
Test for endotoxin contamination if the protein will be used in immunological studies
Confirm purity by SDS-PAGE (aim for >95% purity)
Comprehensive characterization of C. concisus NDK activity requires multiple complementary approaches:
Coupled spectrophotometric assay:
Principle: NDK transfers phosphate from NTP to NDP, with the generated NTP used by pyruvate kinase to convert phosphoenolpyruvate to pyruvate, which is then reduced by lactate dehydrogenase with concomitant oxidation of NADH
Detection: Decrease in NADH absorbance at 340 nm
Advantages: Continuous monitoring, high sensitivity
Considerations: Potential interference from coupling enzymes
Direct nucleotide conversion assay:
Principle: Direct monitoring of NDP to NTP conversion
Methods: HPLC separation and quantification of nucleotides
Advantages: Direct measurement of substrate and product
Considerations: Requires specialized equipment, not continuous
Phosphate release assay:
Principle: Measurement of inorganic phosphate released during reaction
Methods: Malachite green or other phosphate detection reagents
Advantages: Simple, colorimetric detection
Considerations: Endpoint assay, less specific
Parameters to optimize include:
pH (typically 7.0-8.0)
Divalent cation concentration (Mg²⁺, Mn²⁺)
Temperature (30-37°C)
Substrate concentrations for kinetic analysis
A comprehensive substrate specificity profile is essential for characterizing C. concisus NDK:
Donor nucleotide screening:
Test all common NTPs (ATP, GTP, CTP, UTP)
Determine relative efficiency as phosphate donors
Measure kinetic parameters (Km, kcat, kcat/Km) for each
Acceptor nucleotide screening:
Test all common NDPs (ADP, GDP, CDP, UDP)
Determine relative efficiency as phosphate acceptors
Measure kinetic parameters for each
Non-canonical substrate testing:
Deoxynucleotides (dADP, dGDP, dCDP, dTDP)
Modified nucleotides (e.g., methylated, oxidized)
Nucleotide analogs with potential inhibitory activity
Data presentation format:
| Donor | Acceptor | Km (μM) | kcat (s⁻¹) | kcat/Km (M⁻¹s⁻¹) | Relative Efficiency (%) |
|---|---|---|---|---|---|
| ATP | GDP | [value] | [value] | [value] | [value] |
| ATP | CDP | [value] | [value] | [value] | [value] |
| [etc] | [etc] | [value] | [value] | [value] | [value] |
Comparative analysis:
Compare substrate profiles between GS1 and GS2 NDK variants
Compare with NDK from other Campylobacter species
Correlate differences with structural features
Robust experimental design requires comprehensive controls:
Enzyme controls:
Active enzyme: Freshly purified recombinant C. concisus NDK
Negative control: Heat-inactivated (95°C, 10 min) enzyme preparation
Positive control: Commercial NDK (e.g., from bovine or E. coli)
Catalytic mutant: If available, a site-directed mutant of a key catalytic residue
Substrate controls:
No-donor control: Reaction mixture lacking NTP donor
No-acceptor control: Reaction mixture lacking NDP acceptor
Background hydrolysis: Monitor NTP hydrolysis in absence of enzyme
Substrate purity: Verify nucleotide purity by HPLC
Assay validation controls:
Linear response: Verify linearity with enzyme concentration
Time course: Ensure measurements in initial velocity range
Reproducibility: Perform at least three independent experiments
Buffer controls: Test effects of buffer components on activity
Data analysis considerations:
Blank subtraction: Account for background signals
Normalization: Express activity per μg or nmol of enzyme
Statistical analysis: Apply appropriate statistical tests
Outlier identification: Use systematic approaches to identify outliers
Structural characterization provides fundamental insights into C. concisus NDK:
Homology modeling approach:
Use existing bacterial NDK structures as templates
Generate separate models for GS1 and GS2 variants
Validate models using energy minimization and Ramachandran analysis
Compare active site architectures between variants
X-ray crystallography:
Crystallization screening with purified protein (>95% purity)
Co-crystallization with substrate analogs or product
Structure determination and refinement
Comparative analysis with related NDK structures
Key structural features to analyze:
Active site architecture and catalytic residues
Substrate binding pocket
Oligomerization interfaces
Surface electrostatic properties
Potential unique features compared to other bacterial NDKs
Structure-function correlations:
Map conservation between GS1 and GS2 variants onto structure
Identify potential genomospecies-specific structural differences
Design structure-guided mutations to test functional hypotheses
Correlate structural features with substrate specificity profiles
NDK proteins in other bacterial pathogens have demonstrated roles in virulence, suggesting potential pathogenic mechanisms for C. concisus NDK:
Potential intracellular functions:
Nucleotide pool maintenance during intestinal colonization
Adaptation to stress conditions (oxidative stress, nutrient limitation)
Contribution to DNA repair mechanisms
Metabolic adaptation between oral and intestinal environments
Potential extracellular functions:
Modulation of extracellular nucleotide concentrations
Interference with host purinergic signaling
Modification of intestinal epithelial cell responses
Contribution to immune evasion strategies
Host response considerations:
Potential immunogenicity of C. concisus NDK
Detection of anti-NDK antibodies in IBD patients
Role in triggering inflammatory responses
Differential responses between genomospecies variants
Research approaches:
Gene knockout studies in C. concisus (challenging due to limited genetic tools)
Recombinant protein addition to epithelial cell models
Protein-protein interaction studies with host factors
Comparison of NDK properties between strains with different virulence
C. concisus detection shows significant association with IBD, suggesting potential diagnostic applications:
NDK-based detection strategies:
Serological approaches:
Development of anti-NDK antibody detection assays
Correlation of antibody levels with disease activity
Distinction between antibody responses to GS1 versus GS2 NDK
Potential prognostic value of anti-NDK antibody patterns
Activity-based detection:
Development of NDK activity assays in clinical samples
Correlation of activity levels with bacterial load
Inhibitor screening for specific C. concisus NDK inhibition
Potential for rapid colorimetric detection methods
Clinical correlation studies:
Association of specific NDK variants with disease phenotypes
Longitudinal studies of NDK detection and disease progression
Relationship between NDK detection and treatment response
Correlation with other inflammatory or microbiome markers
Genomic analysis can provide essential context for NDK studies:
Comprehensive NDK sequence comparison:
Genomic context analysis:
Examination of NDK gene neighborhood across strains
Identification of potential co-regulated genes
Analysis of promoter regions and regulatory elements
Investigation of horizontal gene transfer evidence
Multi-locus approaches:
Include NDK in multi-locus sequence typing schemes
Compare phylogenetic trees based on NDK versus whole-genome data
Evaluate NDK as a potential marker for strain typing
Correlation of NDK variants with virulence-associated genes
Transcriptomic integration:
Analysis of NDK expression under different conditions
Correlation with expression of other virulence factors
Differential expression between GS1 and GS2 strains
Response to host-derived signals or stressors
Emerging technologies offer new opportunities for NDK research:
CRISPR-Cas9 approaches:
Development of genetic manipulation tools for C. concisus
Precise editing of the NDK gene
Creation of reporter strains for NDK expression studies
Generation of catalytic mutants for function validation
Single-cell techniques:
Single-cell RNA sequencing of C. concisus from clinical samples
Analysis of NDK expression heterogeneity
Correlation with host cell interactions
Spatial transcriptomics in intestinal biopsies
Advanced protein analysis:
Hydrogen-deuterium exchange mass spectrometry for dynamic studies
Native mass spectrometry for oligomeric state analysis
Protein-protein interaction network mapping
In situ structural studies using cryo-electron tomography
High-throughput screening:
Development of NDK activity-based screening assays
Identification of specific inhibitors
Drug repurposing approaches targeting NDK
Screening for compounds that differentially affect GS1 vs. GS2 NDK
Integration across disciplines will advance understanding of C. concisus NDK:
Clinical-basic science collaborations:
Access to well-characterized patient cohorts
Correlation of NDK variants with clinical phenotypes
Longitudinal studies linking NDK detection with disease progression
Evaluation of potential diagnostic applications
Microbiome integration:
Analysis of C. concisus and NDK in the context of microbiome dysbiosis
Interactions between C. concisus and other microbiota members
Effect of microbial metabolites on NDK expression and activity
Competition for nucleotides in complex microbial communities
Immunological perspectives:
Investigation of innate immune responses to C. concisus NDK
Analysis of adaptive immunity and antibody responses
Evaluation of NDK as a potential vaccine component
Roles in immunomodulation during chronic inflammation
Systems biology approaches:
Integration of genomic, transcriptomic, and proteomic data
Metabolic modeling of nucleotide metabolism in C. concisus
Network analysis of NDK interactions in cellular processes
Predictive modeling of NDK contributions to pathogenesis